Analysis of common gene expression patterns in four human tumor cell lines exposed to camptothecin using cDNA microarray: Identification of topoisomerase-mediated DNA damage response pathways

Frontiers in Bioscience

Volumn 11, Issue 2 P.1591-2006, 2006, Pages 1924-1931

  Guo, XueQing ^a   Zhang, JunPing ^b   Fu, XuPing ^a   Wei, Qing ^a   Lu, YingHua ^a   Li, Yao ^a   Yin, Gang ^a   Mao, YuMin ^a   Xie, Yi ^a   Rui, YaoCheng ^b   Ying, Kang ^a  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Camptothecin; Gene Expression Pattern; Microarray

Indexed keywords

ATAXIA;

EID: 32844475319     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1935     Document Type: Article

References (32)

1. Hentze H., M. Latta, G. Kunstle, S. Dhakshinamoorthy, A. G. Porter & A. Wendel: Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis. Hepatology 39 (5), 1311-20 (2004)
2. Sordet O., Q. A. Khan, K. W. Kohn & Y. Pommier: Apoptosis induced by topoisomerase inhibitors. Curr Med Chem Anti-Canc Agents 3 (4), 271-90 (2003)
3. Zhou Y., F. G. Gwadry, W. C. Reinhold, L. D. Miller, L. H. Smith, U. Scherf, E. T. Liu, K. W. Kohn, Y. Pommier & J. N. Weinstein: Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage:microarray analysis of dose- and time-dependent effects. Cancer Res. 62 (6), 1688-95 (2002)
4. Ullmannova V. & C. Haskovec: Gene expression during camptothecin-induced apoptosis in human myeloid leukemia cell line ML-2. Neoplasma 51 (3), 175-80 (2004)
5. Schena M., D. Shalon, R. W. Davis & P. O. Brown: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (5235), 467-70 (1995)
6. Brachat A., B. Pierrat, A. Xynos, K. Brecht, M. Simonen, A. Brungger & J. Heim: A microarray-based, integrated approach to identify novel regulators of cancer drug response and apoptosis. Oncogene 21 (54), 361-71 (2002)
7. Zhang J. P., K. Ying, Z. Y. Xiao, B. Zhou, Q. S. Huang, H. M. Wu, M. Yin, Y. Xie, Y. M. Mao & Y. C. Rui: Analysis of gene expression profiles in human HL-60 cell exposed to cantharidin using cDNA microarray. Int J Cancer 108 (2), 212-8 (2004).
8. Wan Y. F., X. Q. Guo, Z. H. Wang, K. Ying & M. H. Yao: Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells. Acta Pharmacol Sin. 25 (3), 378-84 (2004)
9. Pacek M. & J. C. Walter: A requirement for MCM7 and Cdc45 in chromosome unwinding during eukaryotic DNA replication. EMBO J. 23 (18), 3667-76 (2004)
10. Cortez D., G. Glick & S. J. Elledge: Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc Natl Acad Sci U S A. 101 (27), 0078-83 (2004).
11. Bondar T., E. V. Mirkin, D. S. Ucker, W. E. Walden, S. M. Mirkin & P. Raychaudhuri: Schizosaccharomyces pombe Ddb1 is functionally linked to the replication checkpoint pathway. J Biol Chem. 278 (39), 37006-14 (2003)
12. Yu Q., J. H. Rose, H. Zhang & Y. Pommier: Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells. FEBS Lett. 505 (1), 7-12 (2001).
13. Crighton D. & K. M. Ryan: Splicing DNA-damage responses to tumour cell death. Biochim Biophys Acta. 1705 (1), 3-15 (2004).
14. Spain B. H., K. S. Bowdish, A. R. Pacal, S. F. Staub, D. Koo, C. Y. Chang, W. Xie & J. ColicelliJ: Two human cDNAs, including a homolog of Arabidopsis FUS6 (COP11), suppress G-protein- and mitogen-activated protein kinase-mediated signal transduction in yeast and mammalian cells. Mol Cell Biol. 16 (12), 6698-706 (1996).
15. Yang J. J: Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest. Biochem Biophys Res Commun. 297 (1), 105-10 (2002)
16. Nicholson K. M. & N. G. Anderson: The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 14 (5), 381-95 (2002)
17. Reinhold W. C., H. Kouros-Mehr, K. W. Kohn, A. K. Maunakea, S. Lababidi, A. Roschke, K. Stover, J. Alexander, P. Pantazis, L. Miller, E. Liu, I. R. Kirsch, Y. Urasaki, Y. Pommier & J. N. Weinstein: Apoptotic susceptibility of cancer cells selected for camptothecin resistance, gene expression profiling, functional analysis, and molecular interaction mapping. Cancer Res. 63 (5), 1000-11 (2003).
18. Martelli A. M., P. L. Tazzari, G. Tabellini, R. Bortul, A. M. Billi, L. Manzoli, A. Ruggeri, R. Conte & L. Cocco: A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia. 17 (9), 1794-805 (2003).
19. Kim R.: Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer. 103 (8), 1551-60 (2005).
20. Belzacq A. S., H. L. Vieira, G. Kroemer, & C. Brenner: The adenine nucleotide translocator in apoptosis. Biochimie. 84 (2-3), 167-76 (2002)
21. Kim J. S., L. He & J. J. Lemasters: Mitochondrial permeability transition, a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun. 304 (3), 463-70 (2003)
22. Hipkiss A. R: Errors, mitochondrial dysfunction and ageing. Biogerontology. 4 (6), 397-400 (2003)
23. Rao R. V., H. M. Ellerby & D. E: Bredesen. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 11 (4), 372-80 (2004)
24. Kelleher D. J., D. Karaoglu, E. C. Mandon & R. Gilmore: Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. Mol Cell. 12 (1), 101-11 (2003)
25. Sanjay A., J. Fu & G. Kreibich: DAD1 is required for the function and the structural integrity of the oligosaccharyltransferase complex. J Biol Chem. 273 (40), 26094-9 (1998).
26. Mkrtchian S., C. Fang, U. Hellman & M. Ingelman-Sundberg. A stress-inducible rat liver endoplasmic reticulum protein, ERp29. Eur J Biochem. 251 (1-2), 304-13 (1998)
27. Nebenfuhr A., C. Ritzenthaler, D. G. Robinson & A. Brefeldin: deciphering an enigmatic inhibitor of secretion. Plant Physiol. 130 (3), 1102-8 (2002).
28. Magill L., B. Walker & A. E. Irvine: The proteasome, a novel therapeutic target in haematopoietic malignancy. Hematology. 8 (5), 275-83 (2003)
29. Huang T. T., S. M. Wuerzberger-Davis, B. J. Seufzer, S. D. Shumway, T. Kurama, D. A. Boothman & S. Miyamoto: NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. J Biol Chem. 275 (13), 9501-9 (2000)
30. Yamamoto S., Y. Tomita, Y. Hoshida, M. Sakon, M. Kameyama, S. Imaoka, M. Sekimoto, S. Nakamori, M. Monden & K. Aozasa: Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Clin Cancer Res 10 (2), 651-7 (2004)
31. Tsujimoto Y., Y. Tomita, Y. Hoshida, T. Kono, T. Oka, S. Yamamoto, N. Nonomura, A. Okuyama & K. Aozasa: Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res. 10 (9), 3007-12 (2004)
32. Asai T., Y. Tomita, S. Nakatsuka, Y. Hoshida, A. Myoui, H. Yoshikawa & K. Aozasa: VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res. 93 (3), 296-304 (2003)